GABA
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Gabather is a pharmaceutical company whose business focus is to develop drug candidates for the treatment of neurological diseases. The focus is particularly on the stimulation of gamma-aminobutyric acid, which is the main inhibitory neurotransmitter in the brain. The drug candidates are patented on a global level. Gabather was established in 2014 and is headquartered in Malmö.
Read moreEPS (adj.)
Dividend %
General meeting '26
Interim report Q2'26
Interim report Q3'26
Don't miss out - create an account and get all the possible benefits